Real world switching therapies analysis in a retro-prospective cohort of patients with multiple sclerosis

被引：0
|
作者：
Mallucci, G. [1 ]
Zito, A. [1 ]
Bergamaschi, R. [1 ]
机构：
[1] IRCCS Mondino, Pavia, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P846
引用
收藏
页码：696 / 697
页数：2
相关论文
共 50 条
  • [1] Biotin in multiple sclerosis in real world: a cohort of 50 patients
    Fromont, A.
    Romain, G.
    Vialatte, A. L.
    Maugest, L.
    Audry, D.
    Moreau, T.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 372 - 372
  • [2] Secondary prevention and follow-up of patients with ACS and not-at-target LDL: An Italian real-world retro-prospective analysis by the INERTIA group
    Del Pinto, Maurizio
    Amico, Francesco
    Brunetti, Natale
    Caldarola, Pasquale
    Carugo, Stefano
    Cavallini, Claudio
    D'Andrea, Antonello
    Fedele, Francesco
    Mauro, Ciro
    Noussan, Patrizia
    Paioscia, Leonardo
    Prati, Francesco
    Tarzia, Pierpaolo
    Tespili, Maurizio
    Barbieri, Lucia
    Basso, Pierangelo
    Buono, Andrea
    D'Alleva, Alberto
    Giubilato, Simona
    Iannacone, Mario
    Ferrante, Fabio
    Granata, Giuseppina
    Ieva, Riccardo
    Madrid, Alfredo
    Mallus, Maria Teresa
    Tagliamonte, Ercole
    INTERNATIONAL JOURNAL OF CARDIOLOGY CARDIOVASCULAR RISK AND PREVENTION, 2023, 17
  • [3] Carfilzomib plus dexamethasone in patients with relapsed and refractory multiple myeloma: A retro-prospective observational study
    Del Giudice, Maria Livia
    Gozzetti, Alessandro
    Antonioli, Elisabetta
    Attucci, Irene
    Pengue, Ludovica
    Cassano Cassano, Raffaella
    Ghio, Francesco
    Orciuolo, Enrico
    Simoncelli, Martina
    Bocchia, Monica
    Galimberti, Sara
    Buda, Gabriele
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 109 (04) : 373 - 380
  • [4] Switching Therapies in Multiple Sclerosis
    Patricia K. Coyle
    CNS Drugs, 2013, 27 : 239 - 247
  • [5] Switching Therapies in Multiple Sclerosis
    Coyle, Patricia K.
    CNS DRUGS, 2013, 27 (04) : 239 - 247
  • [6] Belantamab mafodotin in triple-refractory multiple myeloma patients: A retro-prospective observational study in Italy
    Fazio, Francesca
    Petrucci, Maria Teresa
    Corvatta, Laura
    Piciocchi, Alfonso
    Pepa, Roberta Della
    Tacchetti, Paola
    Musso, Maurizio
    Zambello, Renato
    Belotti, Angelo
    Bringhen, Sara
    Antonioli, Elisabetta
    Conticello, Concetta
    Renzo, Nicola Di
    De Stefano, Valerio
    Musto, Pellegrino
    Gamberi, Barbara
    Derudas, Daniele
    Boccadoro, Mario
    Offidani, Massimo
    More, Sonia
    EJHAEM, 2024, 5 (03): : 485 - 493
  • [7] Safety of daclizumab discontinuation in a cohort of multiple sclerosis patients in real world monitoring
    Mallucci, G.
    Maregatti, M. C.
    Romani, A.
    Bergamaschi, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 671 - 671
  • [8] Disease trajectory of high neuroticism and the relevance to psychiatric disorders: A retro-prospective cohort study
    Xia, Ding
    Han, Xin
    Zeng, Yu
    Wang, Jingru
    Xu, Kelin
    Zhang, Tiejun
    Jiang, Yanfeng
    Chen, Xingdong
    Song, Huan
    Suo, Chen
    ACTA PSYCHIATRICA SCANDINAVICA, 2024, 149 (02) : 133 - 146
  • [9] A real-world cohort analysis of alemtuzumab outcomes in relapsing multiple sclerosis
    Herman, Jorge Acevedo
    Khalighinejad, Farnaz
    York, Katherine
    Radu, Irina
    Morales, Idanis Berrios
    Ionete, Carolina
    Hemond, Christopher C.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 47
  • [10] Real-world outcomes of teriflunomide in relapsing–remitting multiple sclerosis: a prospective cohort study
    Yao Zhang
    Hexiang Yin
    Dingding Zhang
    Yan Xu
    Bin Peng
    Liying Cui
    Journal of Neurology, 2022, 269 : 4808 - 4816
12345